Reactivation tuberculosis: role of surveillance

Expert Rev Anti Infect Ther. 2016;14(5):501-9. doi: 10.1586/14787210.2016.1173541.

Abstract

The incidence and death rates from tuberculosis (TB) have declined through concerted efforts in the diagnosis and treatment of active disease. Despite this, 9.6 million new cases and 1.1 million deaths in 2014 are unacceptably high. To decrease the rates of TB further, the huge number of persons with latent TB infection (LTBI) from whom new cases will arise has to be addressed with a sense of priority. Identifying the highest risk groups and providing effective treatment has been shown to decrease active TB. Further research to refine the predictors of reactivation and shorter effective treatments are urgently needed. Implementing intensified case finding, testing and treatment for LTBI will require continued investment in health care capacity at multiple levels.

Keywords: HIV; Tuberculosis; intensive case finding; latent tuberculosis therapy; reactivation.

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Antitubercular Agents / therapeutic use
  • Humans
  • Latent Tuberculosis / diagnosis
  • Latent Tuberculosis / drug therapy
  • Latent Tuberculosis / epidemiology
  • Population Surveillance*
  • Risk Factors
  • Tuberculosis / diagnosis*
  • Tuberculosis / drug therapy
  • Tuberculosis / epidemiology

Substances

  • Antitubercular Agents